ãã®ã¬ãã¼ãã¯ãGlobal APO E éºä¼åæ¤æ» ã®æ½è±¡çãã¤å®éçãªèª¿æ»ãæä¾ãã¾ãã調æ»ã¯ãAPO E éºä¼åæ¤æ» ã®æ¹åã«å½±é¿ãä¸ããééçããã³éééé¢é£ã®è¦å ã«ç¦ç¹ãå½ã¦ã APO E éºä¼åæ¤æ» ã®åå²ã«â¦ ç¶ããèªã APO E éºä¼åæ¤æ»å¸å ´ 2031 å¹´ã®æé·ãã©ã¤ãã¼ã¨ããããã¬ã¼ã¤ã¼ â 23andMeãLabCorpãEmpower DXãMega GenomicsãBlueprin
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}